# FDA Inspection 1210613 - Misako (NMI) Nagasaka, M.D. - July 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/misako-nmi-nagasaka-md/c6b71c1d-c6db-410b-b210-eb64cad4cc70
Source feed: FDA_Inspections

> FDA Inspection 1210613 for Misako (NMI) Nagasaka, M.D. on July 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210613
- Company Name: Misako (NMI) Nagasaka, M.D.
- Inspection Date: 2023-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/misako-nmi-nagasaka-md/ff46af72-03c5-4756-bf31-1d33cbaef862

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c